Uncategorised - European Medical Journal

Improving Quality of Life in Liver Cancer Treatment

Discover a new study that combined selective internal radiation therapy with nivolumab for patients with HCC.

ViiV, Roche and Gilead lead pharma patient group rankings

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the industry can improve.

Risks of Nonroutine Discharge After Spinal Metastasis Surgery

Patients undergoing spinal surgery for metastatic disease face a heightened risk of nonroutine discharge, often leading to increased healthcare costs and higher readmission rates.

Fewer Complications with Injectable Hydrogel for Stress Incontinence, Study Finds

Hydrogel safer but less satisfying than mesh in long-term stress incontinence treatment, study finds.

Low CALLY Index Linked to Higher Mortality in Rheumatoid Arthritis

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in rheumatoid arthritis patients.

Buprenorphine Treatment Reduces Preterm Birth and NICU Admissions

A major study has shown that pregnant individuals treated with buprenorphine for opioid use disorder have lower risks of severe complications, preterm birth, and NICU admissions.

Mixed Reality Technology Improves Outcomes in Colon Cancer Surgery

New research highlights the benefits of using Mixed Reality (MR) technology during right hemicolectomy for colon cancer.

Mind Over Microbiota: Brain Rapidly Rewrites Gut Bacteria

Discover a study where researchers administered appetite-related hormones leptin and ghrelin directly into the brain.

Simple Blood Test Marker May Predict GI Cancer Risk

A new analysis from nearly 20,000 participants in the U.S. NHANES study has identified the platelet-to-high-density lipoprotein ratio (PHR) as a strong predictor of gastrointestinal cancer risk.

Is Parkinson’s Disease Rooted in the Gut?

Parkinson’s disease (PD), a progressive neurodegenerative disorder impacting over 10 million people worldwide, is defined by the aggregation of misfolded α-synuclein (aSyn) in the substantia nigra pars compacta, leading to the hallmark motor symptoms of tremor, rigidity, and bradykinesia.